Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis.

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil.

A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.

Antiretroviral therapy.

HIV status disclosure and associated outcomes among pregnant women enrolled in antiretroviral therapy in Uganda: a mixed methods study.

Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure.

Antiretroviral therapy: when to start.

Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.

Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Antiretroviral therapy initiation in an Australian cohort: implications for increased use of antiretroviral therapy.

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.

Changes in metabolic syndrome status after initiation of antiretroviral therapy.

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.

Long-term effect of highly active antiretroviral therapy on immunologic features in children.

Antiretroviral therapy-induced lipodystrophy.

Antiretroviral therapy: current drugs.

Initiation of antiretroviral therapy.

Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.

African ancestry influences CCR5 -2459G>A genotype-associated virologic success of highly active antiretroviral therapy.

Current status of HIV therapy: I. Antiretroviral agents.

Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.

ritonavir-containing first-line antiretroviral therapy in South Africa.

Beginning antiretroviral therapy for patients with HIV.

Suggest Documents

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis.

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil.

A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.

Antiretroviral therapy.

HIV status disclosure and associated outcomes among pregnant women enrolled in antiretroviral therapy in Uganda: a mixed methods study.

Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure.

Antiretroviral therapy: when to start.

Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.

Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Antiretroviral therapy initiation in an Australian cohort: implications for increased use of antiretroviral therapy.

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.

Changes in metabolic syndrome status after initiation of antiretroviral therapy.

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.

Long-term effect of highly active antiretroviral therapy on immunologic features in children.

Antiretroviral therapy-induced lipodystrophy.

Antiretroviral therapy: current drugs.

Initiation of antiretroviral therapy.

Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.

African ancestry influences CCR5 -2459G>A genotype-associated virologic success of highly active antiretroviral therapy.

Current status of HIV therapy: I. Antiretroviral agents.

Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.

ritonavir-containing first-line antiretroviral therapy in South Africa.

Beginning antiretroviral therapy for patients with HIV.

Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?

Recommend Documents

Follow Us